DYRK1A: A Promising Drug Target for Islet Transplant–Based Diabetes Therapies
- 1Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany
- 2Institute for Metabolic Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- Corresponding author: Eckhard Lammert, lammert{at}hhu.de.
Article Information
vol. 65 no. 6 1496-1498
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print May 24, 2016.
Copyright & Usage
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Author Information
- 1Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany
- 2Institute for Metabolic Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- Corresponding author: Eckhard Lammert, lammert{at}hhu.de.